Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 19, 2024
04 June 2024 - 1:45AM
Business Wire
Regulatory News:
The shareholders of Median Technologies (FR0011049824, ALMDT,
PEA/PME scheme eligible, “Median” or “The Company”) are invited to
participate in the Shareholders’ Ordinary and Extraordinary General
Meeting which will be held on Wednesday June 19, 2024, at 5:00 pm
CEST at PDGB, 174 avenue Victor Hugo – 75116 Paris.
All useful information relating to this Shareholders’ General
Meeting is regularly updated on Median Technologies’ website.
Shareholders may exercise their voting rights before the holding
of the Shareholders’ General Meeting, either by returning their
postal voting form, or by giving proxy. The detailed procedures
relating to the exercise of the right to vote are specified in the
notice of the Shareholders’ General Meeting, available here on
Median’s website.
The preliminary notice of the Shareholders’ General Meeting has
been published in the BALO (Bulletin des annonces légales
obligatoires) on May 13, 2024, and has not been subject to any
modification.
The documents referred to in Article R.225-83 of the French
Commercial Code are made available to Shareholders as from the date
of the convening notice for the Meeting in accordance with
applicable regulations:
- Registered shareholders may, up to and including the fifth day
prior to the Meeting, request that the company sends these
documents to them free of charge. For shareholders holding bearer
shares, the exercise of this right is subject to the provision of a
certificate of registration in the accounts of the bearer shares
issued by the authorized intermediary.
- Shareholders may consult these documents at the company’s
registered office, Les 2 Arcs, 1800 route des Crêtes – 06560
Valbonne, under the conditions provided for by applicable
regulations.
The documents to be communicated within the context of the
Shareholders’ General Meeting may be consulted and downloaded on
Median Technologies’ website under the “Shareholder Meetings”
section here.
About Median Technologies: Pioneering in innovative imaging
solutions and services, Median Technologies harnesses cutting-edge
AI to elevate the accuracy of early cancer diagnoses and cancer
treatments. Median's offerings, including iCRO for medical image
analysis and management in oncology trials and eyonis™, AI/ML
tech-based suite of software as medical devices (SaMD), empower
biopharmaceutical entities and clinicians to advance patient care
and expedite novel therapies. The French-based company, with a
presence in the U.S. and China, trades on the Euronext Growth
market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for
the French SME equity savings plan scheme (PEA-PME). For more
information: www.mediantechnologies.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240603837634/en/
Median Technologies Emmanuelle Leygues Head of Corporate
Marketing & Financial Communications +33 6 10 93 58 88
emmanuelle.leygues@mediantechnologies.com Press - ALIZE RP
Caroline Carmagnol +33 6 64 18 99 59 median@alizerp.com
Investors - ACTIFIN Ghislaine Gasparetto +33 6 21 10 49 24
ghislaine.gasparetto@seitosei-actifin.com
Median Technologies (EU:ALMDT)
Historical Stock Chart
From May 2024 to Jun 2024
Median Technologies (EU:ALMDT)
Historical Stock Chart
From Jun 2023 to Jun 2024